Literature DB >> 20558392

Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

Karen S Marder1, Ming X Tang, Helen Mejia-Santana, Llency Rosado, Elan D Louis, Cynthia L Comella, Amy Colcher, Andrew D Siderowf, Danna Jennings, Martha A Nance, Susan Bressman, William K Scott, Caroline M Tanner, Susan F Mickel, Howard F Andrews, Cheryl Waters, Stanley Fahn, Barbara M Ross, Lucien J Cote, Steven Frucht, Blair Ford, Roy N Alcalay, Michael Rezak, Kevin Novak, Joseph H Friedman, Ronald F Pfeiffer, Laura Marsh, Brad Hiner, Gregory D Neils, Miguel Verbitsky, Sergey Kisselev, Elise Caccappolo, Ruth Ottman, Lorraine N Clark.   

Abstract

BACKGROUND: Mutations in the parkin gene are the most common genetic cause of early-onset Parkinson disease (PD). Results from a multicenter study of patients with PD systematically sampled by age at onset have not been reported to date.
OBJECTIVE: To determine risk factors associated with carrying parkin mutations.
DESIGN: Cross-sectional observational study.
SETTING: Thirteen movement disorders centers. PARTICIPANTS: A total of 956 patients with early-onset PD, defined as age at onset younger than 51 years. MAIN OUTCOME MEASURES: Presence of heterozygous, homozygous, or compound heterozygous parkin mutations.
RESULTS: Using a previously validated interview, 14.7% of patients reported a family history of PD in a first-degree relative. Sixty-four patients (6.7%) had parkin mutations (3.9% heterozygous, 0.6% homozygous, and 2.2% compound heterozygous). Copy number variation was present in 52.3% of mutation carriers (31.6% of heterozygous, 83.3% of homozygous, and 81.0% of compound heterozygous). Deletions in exons 3 and 4 and 255delA were common among Hispanics (specifically Puerto Ricans). Younger age at onset (<40 years) (odds ratio [OR], 5.0; 95% confidence interval [CI], 2.8-8.8; P = .001), Hispanic race/ethnicity (OR compared with white non-Hispanic race/ethnicity, 2.7; 95% CI, 1.3-5.7; P = .009), and family history of PD in a first-degree relative (OR compared with noncarriers, 2.8; 95% CI, 1.5-5.3; P = .002) were associated with carrying any parkin mutation (heterozygous, homozygous, or compound heterozygous). Hispanic race/ethnicity was associated with carrying a heterozygous mutation (OR compared with white non-Hispanic race/ethnicity, 2.8; 95% CI, 1.1-7.2; P = .03) after adjustment for covariates.
CONCLUSIONS: Age at onset, Hispanic race/ethnicity, and family history of PD are associated with carrying any parkin mutation (heterozygous, homozygous, or compound heterozygous) and heterozygous mutations alone. The increased odds of carrying a parkin mutation among Hispanics warrants further study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558392      PMCID: PMC3329757          DOI: 10.1001/archneurol.2010.95

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  51 in total

1.  Role of parkin mutations in 111 community-based patients with early-onset parkinsonism.

Authors:  Martin Kann; Helfried Jacobs; Kathrin Mohrmann; Kirsten Schumacher; Katja Hedrich; Jennifer Garrels; Karin Wiegers; Eberhard Schwinger; Peter P Pramstaller; Xandra O Breakefield; Laurie J Ozelius; Peter Vieregge; Christine Klein
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

2.  Parkin mutations are frequent in patients with isolated early-onset parkinsonism.

Authors:  Magali Periquet; Morwena Latouche; Ebba Lohmann; Nina Rawal; Giuseppe De Michele; Sylvain Ricard; Hélio Teive; Valérie Fraix; Marie Vidailhet; David Nicholl; Paolo Barone; Nick W Wood; Salmo Raskin; Jean-François Deleuze; Yves Agid; Alexandra Dürr; Alexis Brice
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

3.  SIFT: Predicting amino acid changes that affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

5.  Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease.

Authors:  T Foroud; S K Uniacke; L Liu; N Pankratz; A Rudolph; C Halter; C Shults; K Marder; P M Conneally; W C Nichols
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

6.  A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.

Authors:  N Abbas; C B Lücking; S Ricard; A Dürr; V Bonifati; G De Michele; S Bouley; J R Vaughan; T Gasser; R Marconi; E Broussolle; C Brefel-Courbon; B S Harhangi; B A Oostra; E Fabrizio; G A Böhme; L Pradier; N W Wood; A Filla; G Meco; P Denefle; Y Agid; A Brice
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

7.  The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.

Authors:  M X Tang; Y Stern; K Marder; K Bell; B Gurland; R Lantigua; H Andrews; L Feng; B Tycko; R Mayeux
Journal:  JAMA       Date:  1998-03-11       Impact factor: 56.272

8.  Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.

Authors:  Sofia A Oliveira; William K Scott; Eden R Martin; Martha A Nance; Ray L Watts; Jean P Hubble; William C Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; William G Ondo; Fred H Allen; Burton L Scott; Christopher G Goetz; Gary W Small; Frank Mastaglia; Jeffrey M Stajich; Fengyu Zhang; Michael W Booze; Michelle P Winn; Lefkos T Middleton; Jonathan L Haines; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

9.  Relative high frequency of the c.255delA parkin gene mutation in Spanish patients with autosomal recessive parkinsonism.

Authors:  E Muñoz; E Tolosa; P Pastor; M J Martí; F Valldeoriola; J Campdelacreu; R Oliva
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

10.  Influence of education and occupation on the incidence of Alzheimer's disease.

Authors:  Y Stern; B Gurland; T K Tatemichi; M X Tang; D Wilder; R Mayeux
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272

View more
  31 in total

1.  The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study.

Authors:  Madeleine E Sharp; Elise Caccappolo; Helen Mejia-Santana; Ming-X Tang; Llency Rosado; Martha Orbe Reilly; Diana Ruiz; Elan D Louis; Cynthia Comella; Martha Nance; Susan Bressman; William K Scott; Caroline Tanner; Cheryl Waters; Stanley Fahn; Lucien Cote; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald Pfeiffer; Haydeh Payami; Eric Molho; Stuart A Factor; John Nutt; Carmen Serrano; Maritza Arroyo; Michael W Pauciulo; William C Nichols; Lorraine N Clark; Roy N Alcalay; Karen S Marder
Journal:  Mov Disord       Date:  2014-11-12       Impact factor: 10.338

2.  Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.

Authors:  Elise Caccappolo; Roy N Alcalay; Helen Mejia-Santana; Ming-X Tang; Brian Rakitin; Llency Rosado; Elan D Louis; Cynthia L Comella; Amy Colcher; Danna Jennings; Martha A Nance; Susan Bressman; William K Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl Waters; Stanley Fahn; Lucien J Cote; Steven Frucht; Blair Ford; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Brad Hiner; Andrew D Siderowf; Barbara M Ross; Miguel Verbitsky; Sergey Kisselev; Ruth Ottman; Lorraine N Clark; Karen S Marder
Journal:  J Int Neuropsychol Soc       Date:  2010-11-24       Impact factor: 2.892

3.  Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations.

Authors:  Hee Jin Kim; Han-Joon Kim; Jee-Young Lee; Ji Young Yun; So Yeon Kim; Sung Sup Park; Beom S Jeon
Journal:  J Neurol       Date:  2011-05-29       Impact factor: 4.849

4.  iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.

Authors:  Chris M Woodard; Brian A Campos; Sheng-Han Kuo; Melissa J Nirenberg; Michael W Nestor; Matthew Zimmer; Eugene V Mosharov; David Sulzer; Hongyan Zhou; Daniel Paull; Lorraine Clark; Eric E Schadt; Sergio Pablo Sardi; Lee Rubin; Kevin Eggan; Mathew Brock; Scott Lipnick; Mahendra Rao; Stephen Chang; Aiqun Li; Scott A Noggle
Journal:  Cell Rep       Date:  2014-11-06       Impact factor: 9.423

5.  Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

Authors:  R N Alcalay; E Caccappolo; H Mejia-Santana; M -X Tang; L Rosado; M Orbe Reilly; D Ruiz; B Ross; M Verbitsky; S Kisselev; E Louis; C Comella; A Colcher; D Jennings; M Nance; S Bressman; W K Scott; C Tanner; S Mickel; H Andrews; C Waters; S Fahn; L Cote; S Frucht; B Ford; M Rezak; K Novak; J H Friedman; R Pfeiffer; L Marsh; B Hiner; A Siderowf; H Payami; E Molho; S Factor; R Ottman; L N Clark; K Marder
Journal:  Neurology       Date:  2012-03-21       Impact factor: 9.910

6.  Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.

Authors:  R N Alcalay; A Siderowf; R Ottman; E Caccappolo; H Mejia-Santana; M-X Tang; L Rosado; E Louis; D Ruiz; C Waters; S Fahn; L Cote; S Frucht; B Ford; M Orbe-Reilly; B Ross; M Verbitsky; S Kisselev; C Comella; A Colcher; D Jennings; M Nance; S Bressman; W K Scott; C Tanner; S Mickel; M Rezak; K E Novak; J H Friedman; R Pfeiffer; L Marsh; B Hiner; L N Clark; K Marder
Journal:  Neurology       Date:  2010-12-29       Impact factor: 9.910

7.  Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.

Authors:  Asad A Aboud; Andrew M Tidball; Kevin K Kumar; M Diana Neely; Kevin C Ess; Keith M Erikson; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2012-10-22       Impact factor: 4.294

8.  High-resolution survey in familial Parkinson disease genes reveals multiple independent copy number variation events in PARK2.

Authors:  Liyong Wang; Karen Nuytemans; Guney Bademci; Cherylyn Jauregui; Eden R Martin; William K Scott; Jeffery M Vance; Stephan Zuchner
Journal:  Hum Mutat       Date:  2013-05-28       Impact factor: 4.878

Review 9.  Mitochondrial dynamics in neurodegeneration.

Authors:  Kie Itoh; Ken Nakamura; Miho Iijima; Hiromi Sesaki
Journal:  Trends Cell Biol       Date:  2012-11-16       Impact factor: 20.808

10.  Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.

Authors:  Roy N Alcalay; Elise Caccappolo; Helen Mejia-Santana; Ming Xin Tang; Llency Rosado; Martha Orbe Reilly; Diana Ruiz; Elan D Louis; Cynthia L Comella; Martha A Nance; Susan B Bressman; William K Scott; Caroline M Tanner; Susan F Mickel; Cheryl H Waters; Stanley Fahn; Lucien J Cote; Steven J Frucht; Blair Ford; Michael Rezak; Kevin E Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Bradley Hiner; Haydeh Payami; Eric Molho; Stewart A Factor; John G Nutt; Carmen Serrano; Maritza Arroyo; Ruth Ottman; Michael W Pauciulo; William C Nichols; Lorraine N Clark; Karen S Marder
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.